New family of oncogenes discovered:
This article was originally published in Clinica
Executive Summary
Researchers at Johns Hopkins University School of Medicine, Baltimore, Maryland, have discovered what they believe may be a new family of oncogenes. Linda Resar and colleagues report in the August issue of Molecular and Cellular Biology that a protein expressed by the c-myc gene, which has previously been linked to the development of Burkitt's lymphoma and several other cancers, stimulates the expression of a second gene, HMG-I/Y. It is the increased expression of HMG-I/Y that appears to cause normal cells to become malignant.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.